↓ Skip to main content

RAS Mutations in Cutaneous Squamous-Cell Carcinomas in Patients Treated with BRAF Inhibitors

Overview of attention for article published in New England Journal of Medicine, January 2012
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (98th percentile)
  • Good Attention Score compared to outputs of the same age and source (78th percentile)

Citations

dimensions_citation
945 Dimensions

Readers on

mendeley
428 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
RAS Mutations in Cutaneous Squamous-Cell Carcinomas in Patients Treated with BRAF Inhibitors
Published in
New England Journal of Medicine, January 2012
DOI 10.1056/nejmoa1105358
Pubmed ID
Authors

Fei Su, Amaya Viros, Carla Milagre, Kerstin Trunzer, Gideon Bollag, Olivia Spleiss, Jorge S Reis-Filho, Xiangju Kong, Richard C Koya, Keith T Flaherty, Paul B Chapman, Min Jung Kim, Robert Hayward, Matthew Martin, Hong Yang, Qiongqing Wang, Holly Hilton, Julie S Hang, Johannes Noe, Maryou Lambros, Felipe Geyer, Nathalie Dhomen, Ion Niculescu-Duvaz, Alfonso Zambon, Dan Niculescu-Duvaz, Natasha Preece, Lídia Robert, Nicholas J Otte, Stephen Mok, Damien Kee, Yan Ma, Chao Zhang, Gaston Habets, Elizabeth A Burton, Bernice Wong, Hoa Nguyen, Mark Kockx, Luc Andries, Brian Lestini, Keith B Nolop, Richard J Lee, Andrew K Joe, James L Troy, Rene Gonzalez, Thomas E Hutson, Igor Puzanov, Bartosz Chmielowski, Caroline J Springer, Grant A McArthur, Jeffrey A Sosman, Roger S Lo, Antoni Ribas, Richard Marais

Abstract

Cutaneous squamous-cell carcinomas and keratoacanthomas are common findings in patients treated with BRAF inhibitors.

X Demographics

X Demographics

The data shown below were collected from the profiles of 27 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 428 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 5 1%
Germany 4 <1%
United Kingdom 2 <1%
Brazil 1 <1%
Czechia 1 <1%
Taiwan 1 <1%
Italy 1 <1%
Spain 1 <1%
Serbia 1 <1%
Other 0 0%
Unknown 411 96%

Demographic breakdown

Readers by professional status Count As %
Researcher 83 19%
Student > Ph. D. Student 79 18%
Student > Bachelor 44 10%
Student > Master 37 9%
Student > Doctoral Student 32 7%
Other 75 18%
Unknown 78 18%
Readers by discipline Count As %
Medicine and Dentistry 118 28%
Agricultural and Biological Sciences 102 24%
Biochemistry, Genetics and Molecular Biology 79 18%
Chemistry 10 2%
Immunology and Microbiology 7 2%
Other 26 6%
Unknown 86 20%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 68. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 October 2023.
All research outputs
#584,387
of 24,079,362 outputs
Outputs from New England Journal of Medicine
#7,224
of 31,627 outputs
Outputs of similar age
#3,378
of 252,509 outputs
Outputs of similar age from New England Journal of Medicine
#65
of 291 outputs
Altmetric has tracked 24,079,362 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 31,627 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 121.4. This one has done well, scoring higher than 77% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 252,509 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 291 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 78% of its contemporaries.